|
|
|
Pharmaceutical Manufacturing and Packing Sourcer
|
Counterfeit drugs are known to exist in both developed and developing
countries. However, the true extent of the problem is not really known,
since no global study has been carried out. A counterfeit drug is
designed to deceive – particularly if it is copied to make it look like
the original product – and if it comes from a supposedly legitimate
source, purchasers are unlikely to be suspicious.
Martin Dallas
at Essentra discusses how anti-counterfeiting and safety legislation –
together with technological progress and increasingly demanding consumer
requirements – are all contributing to a surge in innovative designs
within the pharma packaging sector (page 40). With the new EU Directive
on counterfeit medicines set to come into force in 2016, there are
significant demands on the industry to both verify authenticity and
demonstrate tamper evidence. As pharma has moved towards compact formats
for package inserts, this has necessitated major investment in new
technology to handle the printing and folding of larger format leaflets,
in order to accommodate the level of detail which ever-increasing
legislation brings.
Moving away from regulatory demands, other
innovations are also playing their part in meeting market requirements.
Dallas is confident, however, that with legislative measures and
packaging technology driving progress within the pharma sector, it is
possible to find the ideal solution to meet the needs of just about any customer – and their consumers.
One
approach in particular which addresses the issue of counterfeit
medicines is highlighted by Ian Lancaster at the International Hologram
Manufacturers Association (page 26). He discusses various solutions –
from holograms to packaging integrating QR codes, coding foils and
virtual identification. Lancaster concludes that one of the reasons for
the success of holograms has been the ability of manufacturers to adapt
them and constantly find new applications. He believes that we will see
more and more interesting developments for the technology over the
coming years, which will undoubtedly offer far-reaching benefits that
advance and expand the role of track and trace.
Of course, it is
no good having distinctive, unique labelling of products if they are
unable to be read and managed by computer systems during storage. This
is a concern that is outlined by Rafael Hernández at Honeywell Scanning
and Mobility (page 48). Freezing temperatures of -30°C not only affect
stored goods, but also all other materials used within the warehouse.
Mobile computers, scanners, printers and voice solutions must therefore
demonstrate exceptional resistance to the growing use of low-temperature
storage.
Hernández reveals how factors such as frost,
condensation, and even cold air can have significant deleterious effects
on the logistics of storage. He gives five tips on how to achieve the
right marriage between printers, devices and labels in the cold store.
Seamless tracking and tracing of goods is essential for a smooth and
efficient flow within the warehouse – and especially so in frozen
storage. The media used play an essential role here, and the most
successful solutions can, as ever, be obtained with the competence and
experience of a reliable provider.
Cold chain and counterfeiting
are just two of the important themes that we have addressed in this
issue of PMPS. In addition, we feature topical articles on pre-filled
syringes, medical device legislation in Japan, automation and blend
uniformity. Finally, make sure you don’t miss either of the interviews
from Air France-KLM-Martinair Cargo (page 46) and DHL (page 70).
|
Read full article from PDF >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
News and Press Releases |
 |
Merck to Provide BioReliance® End-to-End Solutions to Phanes Therapeutics
• Collaboration to accelerate development and manufacturing of Bispecific Antibody
• Merck plans to offer Phanes a full suite of products and services under its BioReliance® offering
More info >> |
|
 |
White Papers |
 |
|
Achieve full compliance with tamper-verification pharma solutions
UPM Raflatac
UPM Raflatac has developed a range of pharmaceutical labelling products to support compliance with the Falsified Medicines Directive on packaging for prescription drugs and high-risk, over-the-counter medicines. Few solutions offer the same ease of adoption for meeting the February 2019 deadline.
More info >> |
|
|
.jpg)
